SCHEMBL16588358

SCHEMBL16588358

C#CCCCOP(OCCC#N)N(C(C)C)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16928602 0.95
SCHEMBL14982551 0.94
SCHEMBL16588334 0.90
SCHEMBL383731 0.87 TSHR (0.32)
SCHEMBL23928776 0.86
SCHEMBL4818972 0.85 TSHR (0.31)
SCHEMBL12733567 0.84 TSHR (0.42)
SCHEMBL14136628 0.83 TSHR (0.30)
SCHEMBL12708582 0.83 CA2 (0.33)
SCHEMBL6357744 0.83 LOX (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3049426-B1 GLYCOCLUSTERS AND THEIR PHARMACEUTICAL USE AS ANTIBACTERIALS CENTRE NAT RECH SCIENT (FR) 2017-11-01 EP disclosed
US-20160287620-A1 GLYCOCLUSTERS AND THEIR PHARMACEUTICAL USE AS ANTIBACTERIALS UNIVERSITE DE MONTPELLIER (FR) 2016-10-06 US disclosed
EP-2851371-A1 Glycoclusters and their pharmaceutical use as antibacterials Centre National de la Recherche Scientifique (CNRS) (FR) 2015-03-25 EP disclosed